02:27 PM EDT, 03/16/2026 (MT Newswires) -- CytomX Therapeutics ( CTMX ) said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.

Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.

Opal Fuels ( OPAL ) is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.

RF Industries ( RFIL ) shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.

Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.

Price: 7.61, Change: +2.93, Percent Change: +62.50